Pharma ACTD Dossiers

Drug Registration in GCC Countries: Requirements, Timelines and Challenges

June 27, 2026 admin

Introduction to GCC Drug Registration The Gulf Cooperation Council (GCC) — comprising Saudi Arabia, UAE, Kuwait, Qatar, Oman, and Bahrain — represents one of the fastest‑growing pharmaceutical markets worldwide. GCC drug registration is a critical step for companies seeking market access, requiring compliance with diverse regulatory frameworks, dossier requirements, and timelines. This article explores the ...
Continue Reading

Global pharmaceutical regulatory Under Fire in 2026: Ukraine, Gaza, Sudan & EU Pharma Package Changes

June 3, 2026 admin

The pharmaceutical industry faces unprecedented regulatory fragmentation in 2026. From war-torn Ukraine to blockade-locked Gaza, collapsing systems in Sudan, US Section 232 tariffs, and the EU's most comprehensive reform in two decades—geopolitical volatility is now a permanent operating condition for pharma companies worldwide. At Pharma ACTD Dossiers, we specialize in preparing ACTD and CTD dossiers ...
Continue Reading

August 2024 Pharma News Roundup

August 25, 2024 admin

In the latest pharma news for August 2024, the pharmaceutical industry continues to see significant developments, including vaccine approvals, regulatory updates, and new funding initiatives. Here are the top stories shaping the landscape: services COVID-19 Vaccine Updates Both Moderna and Pfizer have secured FDA approval for their updated COVID-19 vaccines(FiercePharma). As new variants emerge, these ...
Continue Reading

+91-962-564-5858